Key result
Wearable acoustic cardiography accurately detects LVEF <40% with ~98% diagnostic accuracy.
Why the study?
Preoperative cardiac evaluation based on history and physical examination is subjective, risking delayed diagnosis or excessive echocardiography, motivating evaluation of the diagnostic accuracy of wearable acoustic cardiography for point-of-care screening of left ventricular and significant valvular dysfunction.
Does wearable acoustic cardiography accurately detect LVEF <40% and significant valvular dysfunction in patients undergoing major elective non-cardiac surgery?
Observational (n=262)
No
Does wearable acoustic cardiography accurately detect LVEF <40% and significant valvular dysfunction in patients undergoing major elective non-cardiac surgery?
Answers are grounded in this paper and cite their sources.
Wearable acoustic cardiography accurately screens for LVEF <40% and significant valvular dysfunction preoperatively, improving risk assessment consistency over physical examination alone.
BACKGROUND: Preoperative cardiac evaluation based on history and physical examination is subjective, risking delayed diagnosis or excessive echocardiography. Acoustic cardiography (ACG) synchronizes ECG and heart sound analysis for rapid point-of-care cardiac screening. We evaluated the diagnostic accuracy of wearable ACG for left ventricular dysfunction, significant valvular dysfunction, and the consistency of ACG-aided preoperative risk assessment with expert consensus. METHODS: This prospective single-center study enrolled consecutive patients undergoing major elective non-cardiac surgery. Echocardiography served as the reference standard; the primary endpoint was LVEF <40%. RESULTS: Among 262 patients, ACG showed excellent performance for LVEF <40% (AUC=0.979, sensitivity 93.3%, specificity 96.4%). It achieved substantial agreement with echocardiography for significant valvular dysfunction (κ=0.69). Adding ACG improved consistency with expert consensus versus physical examination alone (κ=0.71 vs 0.55). CONCLUSIONS: Wearable ACG provides high accuracy for preoperative screening of systolic and valvular dysfunction. It facilitates targeted echocardiography referral. Further trials are needed to verify its impact on referral decisions and perioperative outcomes. TRIAL REGISTRATION: ChiCTR2300073695.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) conducted an observational in Left ventricular and valvular dysfunction in patients undergoing major elective non-cardiac surgery (n=262). Wearable acoustic cardiography (ACG) vs. Echocardiography (reference standard) was evaluated on Left ventricular ejection fraction (LVEF) <40% (AUC 0.979). Wearable acoustic cardiography detected LVEF <40% with an AUC of 0.979, sensitivity of 93.3%, and specificity of 96.4% compared with echocardiography.
Synapse has enriched 10 related papers. Consider them for comparative context: